Abbott | Boston Scientific | Medtronic
The CRM (Cardiac Rhythm Management) market is dominated by three major players. Each company publishes Product Performance Reports (PPRs) detailing device implant volumes and reliability data.
Abbott's CRM portfolio includes pacemakers, ICDs, and CRT devices. Known for the St. Jude Medical acquisition which expanded their cardiac device offerings.
| Metric | Value |
|---|---|
| Total Devices | 1,202 |
| Data Coverage | 94.9% |
| Year Range | 2008-2024 |
Boston Scientific offers the DYNAGEN, INOGEN, and ORIGEN family of CRT devices along with a comprehensive ICD portfolio including the S-ICD (subcutaneous) system.
| Metric | Value |
|---|---|
| Total Devices | 163 |
| Data Coverage | 100.0% |
| Year Range | 2014-2024 |
Medtronic is the largest player in the CRM market with the most extensive device portfolio spanning all categories including the Micra leadless pacemaker.
| Metric | Value |
|---|---|
| Total Devices | 924 |
| Data Coverage | 96.0% |
| Year Range | 2008-2024 |
| Company | Code | Devices | Coverage | Specialties |
|---|---|---|---|---|
| Abbott | ABT | 1,202 | 94.9% | CRT-D, Pacemaker |
| Boston Scientific | BSX | 163 | 100.0% | S-ICD, CRT |
| Medtronic | MDT | 924 | 96.0% | Leadless (Micra), Full portfolio |